Investigation of Somatosensory Predictors of Response to Pregabalin in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN)
Phase of Trial: Phase II
Latest Information Update: 26 Apr 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 19 Apr 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2017.
- 19 Apr 2017 Planned primary completion date changed from 1 Mar 2017 to 1 Sep 2017.
- 12 Apr 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.